|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2008-8-1
|
|
pubmed:abstractText |
The aim of this study was to evaluate the potential role of F-18-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in assessing the chemotherapy response of osteosarcoma when compared with histologically assessed tumor necrosis.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0914-7187
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
22
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
475-80
|
|
pubmed:meshHeading |
pubmed-meshheading:18670853-Adolescent,
pubmed-meshheading:18670853-Adult,
pubmed-meshheading:18670853-Antineoplastic Agents,
pubmed-meshheading:18670853-Bone Neoplasms,
pubmed-meshheading:18670853-Chemotherapy, Adjuvant,
pubmed-meshheading:18670853-Child,
pubmed-meshheading:18670853-Female,
pubmed-meshheading:18670853-Fluorodeoxyglucose F18,
pubmed-meshheading:18670853-Humans,
pubmed-meshheading:18670853-Male,
pubmed-meshheading:18670853-Necrosis,
pubmed-meshheading:18670853-Osteosarcoma,
pubmed-meshheading:18670853-Positron-Emission Tomography,
pubmed-meshheading:18670853-Prognosis,
pubmed-meshheading:18670853-Radiopharmaceuticals,
pubmed-meshheading:18670853-Treatment Outcome
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Response of osteogenic sarcoma to neoadjuvant therapy: evaluated by 18F-FDG-PET.
|
|
pubmed:affiliation |
Department of Orthopedics, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China. zhujj666@sohu.com
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|
